Brief: Personalis Announces Start Of Cancer MRD Testing Commercialization Collaboration With Tempus
31/05/2024 14:48
May 31 (Reuters) - Personalis Inc PSNL.O :
* PERSONALIS ANNOUNCES START OF CANCER MRD TESTING
COMMERCIALIZATION COLLABORATION WITH TEMPUS
Source text for Eikon: ID:nBw4JSHm8a
Further company coverage: PSNL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Personalis
See all newsBrief: Personalis - Announces Commercial Launch Of Real-Time Variant Tracker In Next Personal Mrd Test
U.S. STOCKS ON THE MOVE-Becton Dickinson, Constellation Energy, Marvell
Personalis slips as BTIG downgrades, sees no rival bid for Tempus deal
Brief: Personalis Receives New Task Order Under U.S. Veterans Affairs Contract For VA MVP
Personalis, Inc. reports results for the quarter ended June 30 - Earnings Summary